Battling bad news

underlined the importance of organizations protecting the good names they have built over the years.

Written byDavid Meeker
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The article "When Bad News Strikes" by Ed Silverman1 underlined the importance of organizations protecting the good names they have built over the years. But rather than waiting for the bad news to strike, it's essential to determine what threatens the good name and take steps to reduce, or even eliminate, those threats.

Logic suggests that helping to prevent crises should be a fundamental part of every senior executive's portfolio. To that end, we should:

• Take inventory of all of the potential risks that may arise from an organization's activities.

• Measure the potential losses associated with those risks, including the probability of the loss and the impact the loss would have. In order to determine which risks are most serious, establish your priorities for dealing with them.

• Consider your alternatives. This might include avoiding the risk, reducing the chance the loss will occur, or transferring the risk ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies